Oliver Gautschi

Prof. Oliver Gautschi is Chief Physician of Medical Oncology for the Luzerner Kantonsspital (LUKS) Group in Lucerne, Switzerland, and Titular Professor of Medical Oncology at the University of Bern. His work centers on thoracic oncology, including molecularly targeted therapy and immunotherapy for non-small cell lung cancer, and he was first author of the global RET registry study in RET-rearranged lung cancer and a lead investigator on the BRAF-mutant EURAF cohort and the IMMUNOTARGET registry. He serves as Vice-President of the Swiss Academy of Multidisciplinary Oncology (SAMO) and is a member of ESMO, the European Thoracic Oncology Platform, and the IASLC. He is a frequent speaker at major international lung cancer congresses.